Apr. 22 at 2:14 PM
$TLSA I have recently added shares. Was mostly in the 1.60s, but now at 1.20 too.
Fill my last orders at
$1.22 please and lets get ready to rock.
Very bullish since Foralumab works and the FDA has indicated to be satisfied with only 1 confirmatory study needed, so they could start directly with phase 3.
I have been just wondering if this phase 2a should have had a 6 month treatment period instead of a 3 month period, but the open-label follow up should be enough I guess.
Still hoping for accelerated approval, but the effect soze needs to be obvious and large for that.
Expecting a partnership too somewhere down the line, after they have consulted the FDA about the study results and path forward.
